The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Open accessAbstract
Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effects have immunoregulatory potential in autoimmune and inflammatory disorders. Here, we provide an overview of the cyclic AMP axis and its role as a regulator of immune functions and discuss the clinical and translational relevance of interventions with these processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,969
The Gap Junction Communication Channel
Kumar, N. M., & Gilula, N. B. (1996) · Cell · doi:10.1016/s0092-8674(00)81282-9 · Cited by 1,917
An Adenosine 3′,5′-Monophosphate-dependant Protein Kinase from Rabbit Skeletal Muscle
Walsh, D. A., Perkins, J. P., & Krebs, E. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34204-8 · Cited by 1,445
A Family of cAMP-Binding Proteins That Directly Activate Rap1
Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E., & Graybiel, A. M. (1998) · Science · doi:10.1126/science.282.5397.2275 · Cited by 1,362
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234 · cited 1×
“Muscle Treg distinctly express the growth factor amphiregulin, which improves muscle repair by directly acting on muscle satellite cells (114).”
BackgroundConti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES
Sutherland, E. W., & Rall, T. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77423-7 · Cited by 1,076
Cyclic nucleotide research — still expanding after half a century
Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 903
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes
Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D., & Sprent, J. (2006) · Science · doi:10.1126/science.1122927 · Cited by 870
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Gavin, M. A., Torgerson, T. R., Houston, E., deRoos, P., Ho, W. Y., Stray-Pedersen, A., Ocheltree, E. L., Greenberg, P. D., Ochs, H. D., & Rudensky, A. Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509484103 · Cited by 780
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., Hu, C., Stevens, R. M., Day, R. M., Gordon, K. B., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.049 · Cited by 678
Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression
Bopp, T., Becker, C., Klein, M., Klein-Heßling, S., Palmetshofer, A., Serfling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062129 · Cited by 658
Self-citationPhosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648
Hanna, R. N., Carlin, L. M., Hubbeling, H. G., Nackiewicz, D., Green, A. M., Punt, J. A., Geissmann, F., & Hedrick, C. C. (2011) · Nature Immunology · doi:10.1038/ni.2063 · Cited by 639
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Klatzmann, D., & Abbas, A. K. (2015) · Nature Reviews Immunology · doi:10.1038/nri3823 · Cited by 636
CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylation
Kim, H.-P., & Leonard, W. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070109 · Cited by 597
Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565
Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function
de la Rosa, M., Rutz, S., Dorninger, H., & Scheffold, A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425274 · Cited by 545
Webster, K. E., Walters, S., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T., & Sprent, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082824 · Cited by 514
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.-Y., & Jin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200029200 · Cited by 481
Rabe, K. F., Bateman, E. D., O'Donnell, D., Witte, S., Bredenbröker, D., & Bethke, T. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67100-0 · Cited by 475
The NR4A Subgroup: Immediate Early Response Genes with Pleiotropic Physiological Roles
Maxwell, M. A., & Muscat, G. E. O. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04002 · Cited by 448
Cyclic AMP: Master Regulator of Innate Immune Cell Function
Serezani, C. H., Ballinger, M. N., Aronoff, D. M., & Peters-Golden, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0091tr · Cited by 415
Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
Transcription Factors Responsive to cAMP
Sassone-Corsi, P. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.002035 · Cited by 381
Physiological Substrates of cAMP-Dependent Protein Kinase
Shabb, J. B. (2001) · Chemical Reviews · doi:10.1021/cr000236l · Cited by 373
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP
Bystrom, J., Evans, I., Newson, J., Stables, M., Toor, I., van Rooijen, N., Crawford, M., Colville-Nash, P., Farrow, S., & Gilroy, D. W. (2008) · Blood · doi:10.1182/blood-2007-12-129767 · Cited by 331
Vang, T., Torgersen, K. M., Sundvold, V., Saxena, M., Levy, F. O., Skålhegg, B. S., Hansson, V., Mustelin, T., & Taskén, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.497 · Cited by 330
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Sanchez-Toril, F., McIvor, A., Teichmann, P., Bredenbroeker, D., & Fabbri, L. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1563oc · Cited by 325
Hatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.03.011 · Cited by 320
Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool
Vahl, J. C., Drees, C., Heger, K., Heink, S., Fischer, J. C., Nedjic, J., Ohkura, N., Morikawa, H., Poeck, H., Schallenberg, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.012 · Cited by 318
Houslay, M. D., Baillie, G. S., & Maurice, D. H. (2007) · Circulation Research · doi:10.1161/01.res.0000261934.56938.38 · Cited by 317
Rennard, S. I., Calverley, P. M., Goehring, U. M., Bredenbröker, D., & Martinez, F. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-18 · Cited by 284
Pei, L., Castrillo, A., Chen, M., Hoffmann, A., & Tontonoz, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502606200 · Cited by 281
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15506 · Cited by 267 · cited 1×
“It is postulated that blocking of PDE4D in non-target organs promotes emesis (133).”
BackgroundHuang, B., Zhao, J., Lei, Z., Shen, S., Li, D., Shen, G., Zhang, G., & Feng, Z. (2009) · EMBO reports · doi:10.1038/embor.2008.224 · Cited by 256
Adenylyl Cyclase–A-kinase Anchoring Protein Complexes: The Next Dimension in cAMP Signaling
Dessauer, C. W. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059345 · Cited by 254
Cyclic Nucleotide-Gated Ion Channels
Matulef, K., & Zagotta, W. N. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.110701.154854 · Cited by 243
Aronoff, D. M., Canetti, C., Serezani, C. H., Luo, M., & Peters-Golden, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.595 · Cited by 241
Koszalka, P., Özüyaman, B., Huo, Y., Zernecke, A., Flögel, U., Braun, N., Buchheiser, A., Decking, U. K. M., Smith, M. L., Sévigny, J., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000144796.82787.6f · Cited by 236
Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase
Agarwal, N., Lamichhane, G., Gupta, R., Nolan, S., & Bishai, W. R. (2009) · Nature · doi:10.1038/nature08123 · Cited by 228
Capturing adenylyl cyclases as potential drug targets
Pierre, S., Eschenhagen, T., Geisslinger, G., & Scholich, K. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2827 · Cited by 224
A-kinase anchoring proteins: protein kinase A and beyond
Edwards, A. S., & Scott, J. D. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00085-x · Cited by 224
Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells
Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W., Hofmann, J., O’Gorman, W. E., & Abbas, A. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903940 · Cited by 219
Akama, T., Baker, S. J., Zhang, Y.-K., Hernandez, V., Zhou, H., Sanders, V., Freund, Y., Kimura, R., Maples, K. R., & Plattner, J. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.007 · Cited by 218
Structural and functional relationships among the RTX toxin determinants of Gram-negative bacteria
Coote, J. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90688-k · Cited by 217
Legler, D. F., Krause, P., Scandella, E., Singer, E., & Groettrup, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.966 · Cited by 203
Suppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105
Wall, E. A., Zavzavadjian, J. R., Chang, M. S., Randhawa, B., Zhu, X., Hsueh, R. C., Liu, J., Driver, A., Bao, X. R., Sternweis, P. C., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000202 · Cited by 188
Man, H.-W., Schafer, P., Wong, L. M., Patterson, R. T., Corral, L. G., Raymon, H., Blease, K., Leisten, J., Shirley, M. A., Tang, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900210d · Cited by 183
Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5
Cote, R. H. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901212 · Cited by 172
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
Schett, G., Sloan, V. S., Stevens, R. M., & Schafer, P. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10381432 · Cited by 171
16 Structure, function, and regulation of human cAMP-dependent protein kinases
Taskén, K., Skålhegg, B. S., Austlid, T. K., Solberg, R., Knutsen, H. K., Levy, F. O., Sandberg, M., Ørstavik, S., Larsen, T., Johansen, A. K., et al. (1997) · Advances in second messenger and phosphoprotein research · doi:10.1016/s1040-7952(97)80019-5 · Cited by 167
Baumer, W., Hoppmann, J., Rundfeldt, C., & Kietzmann, M. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807780077318 · Cited by 162
Datta, S. K., Sabet, M., Nguyen, K. P. L., Valdez, P. A., Gonzalez-Navajas, J. M., Islam, S., Mihajlov, I., Fierer, J., Insel, P. A., Webster, N. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002348107 · Cited by 158
Phosphodiesterase Inhibitors in the Treatment of Inflammatory Diseases
Page, C. P., & Spina, D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_17 · Cited by 156
Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Zhang, H. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168092 · Cited by 152
Jutila, M. A., Kroese, G. M., Jutila, K. L., Stall, A. M., Fiering, S., Herzenberg, L. A., Berg, E. L., & Butcher, E. C. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181125 · Cited by 151
Selective PDE inhibitors as novel treatments for respiratory diseases
Page, C. P., & Spina, D. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.016 · Cited by 149
TCR- and CD28-Mediated Recruitment of Phosphodiesterase 4 to Lipid Rafts Potentiates TCR Signaling
Abrahamsen, H., Baillie, G. S., Ngai, J., Vang, T., Nika, K., Ruppelt, A., Mustelin, T., Zaccolo, M., Houslay, M. D., & Taskén, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4847 · Cited by 143
Wortis, H. H., Teutsch, M. R., Higer, M., Zheng, J., & Parker, D. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3348 · Cited by 143
Dao, K. K., Teigen, K., Kopperud, R., Hodneland, E., Schwede, F., Christensen, A. E., Martı́nez, A., & Døskeland, S. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603116200 · Cited by 142
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Field, S. K. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s7667 · Cited by 142
Kavanaugh, A., Mease, P. J., Gómez-Reino, J. J., Adebajo, A., Wollenhaupt, J., Gladman, D. D., Hochfeld, M., Teng, L. L., Schett, G. A., Lespessailles, É., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140647 · Cited by 135
Peter, D., Jin, S.-L. C., Conti, M., Hatzelmann, A., & Zitt, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4820 · Cited by 134
Structure, function and evolution of microbial adenylyl and guanylyl cyclases
Baker, D. A., & Kelly, J. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04067.x · Cited by 129
Okumura, S., Kawabe, J.-I., Yatani, A., Takagi, G., Lee, M.-C., Hong, C., Liu, J., Takagi, I., Sadoshima, J., Vatner, D. E., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000086986.35568.63 · Cited by 126
Interferon-α Suppresses cAMP to Disarm Human Regulatory T Cells
Bacher, N., Raker, V., Hofmann, C., Graulich, E., Schwenk, M., Baumgrass, R., Bopp, T., Zechner, U., Merten, L., Becker, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3788 · Cited by 124
Self-citationThe −180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy
Powell, J. D., Lerner, C. G., Ewoldt, G. R., & Schwartz, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6631 · Cited by 124
Oberle, N., Eberhardt, N., Falk, C. S., Krammer, P. H., & Suri‐Payer, E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3578 · Cited by 122
Erdoğan, S., & Houslay, M. D. (1997) · Biochemical Journal · doi:10.1042/bj3210165 · Cited by 120
Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism
Moreno‐Fernandez, M. E., Rueda, C. M., Rusie, L. K., & Chougnet, C. A. (2011) · Blood · doi:10.1182/blood-2010-12-323162 · Cited by 117
Riley, C. L., Boutz, D., Bean, C., Kohno, S., Tioli, G., Genova, M. L., Scorrano, L., & L Mills, E. (2020) · The FASEB Journal · doi:10.1096/fj.1530-6860 · Cited by 112
Hedrich, C. M., Crispín, J. C., Rauen, T., Ioannidis, C., Apostolidis, S. A., Lo, M. S., Kyttaris, V. C., & Tsokos, G. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210129109 · Cited by 111
Discovery of selective PDE4B inhibitors
Naganuma, K., Omura, A., Maekawara, N., Saitoh, M., Ohkawa, N., Kubota, T., Nagumo, H., Kodama, T., Takemura, M., Ohtsuka, Y., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.121 · Cited by 111
Extracellular adenosine regulates naive T cell development and peripheral maintenance
Cekic, C., Sağ, D., Day, Y., & Linden, J. M. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130249 · Cited by 111
Protective immunity induced by Bacillus anthracis toxin-deficient strains
Pezard, C., Weber‐Levy, M., Sirard, J., Berche, P., & Mock, M. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1369-1372.1995 · Cited by 109
AKAPs: The architectural underpinnings of local cAMP signaling
Kritzer, M. D., Li, J., Dodge‐Kafka, K. L., & Kapiloff, M. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.002 · Cited by 109
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases
Beghé, B., Rabe, K. F., & Fabbri, L. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0021pp · Cited by 108
Harizi, H., Juzan, M., Grosset, C. F., Rashedi, M., & Gualde, N. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1785 · Cited by 106
Iwatsubo, K., Minamisawa, S., Tsunematsu, T., Nakagome, M., Toya, Y., Tomlinson, J. E., Umemura, S., Scarborough, R. M., Levy, D. E., & Ishikawa, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314238200 · Cited by 103
The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications
Siuciak, J. A. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00002 · Cited by 100
Fülöp, T., Fóris, G., Wórum, I., & Leovey, A. (1985) · PubMed Central · Cited by 99
Eby, J. C., Gray, M. C., & Hewlett, E. L. (2014) · Infection and Immunity · doi:10.1128/iai.02487-14 · Cited by 93
Tian, J., Rui, K., Tang, X., Ma, J., Wang, Y., Tian, X., Zhang, Y., Xu, H., Lu, L., & Wang, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500209 · Cited by 91
cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes.
Bodor, J., Spetz, A., Strominger, J. L., & Habener, J. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3536 · Cited by 89
Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-β Production
Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L., & Albina, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2125 · Cited by 85
Whalen, M. M., & Bankhurst, A. D. (1990) · Biochemical Journal · doi:10.1042/bj2720327 · Cited by 84
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
Jin, S.-L. C., Lin, S., & Ding, S.-L. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106152 · Cited by 84
Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages
Tenor, H., Hatzelmann, A., Kupferschmidt, R., Stanciu, L. A., Djukanović, R., Schudt, C., Wendel, A., Church, M. K., & Shute, J. K. (1995) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1995.tb01110.x · Cited by 84
The molecular machinery for cAMP-dependent immunomodulation in T-cells
Taskén, K., & Stokka, A. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340476 · Cited by 79
Becker, C., Taube, C., Bopp, T., Becker, C., Michel, K. D., Kubach, J., Reuter, S., Dehzad, N., Neurath, M. F., Reifenberg, K., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206730 · Cited by 79
Self-citationAdenylyl cyclases as innovative therapeutic goals
Pavan, B., Biondi, C., & Dalpiaz, A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.007 · Cited by 78
Torgersen, K. M., Vaage, J. T., Levy, F. O., Hansson, V., Rolstad, B., & Taskén, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5495 · Cited by 77
Lahl, K., Mayer, C. T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., Wirnsberger, G., Dornmair, K., Geffers, R., Schmitt, E., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803762 · Cited by 75
The Interferon Stimulated Gene 12 Inactivates Vasculoprotective Functions of NR4A Nuclear Receptors
Papac-Miličević, N., Breuss, J. M., Zaujec, J., Ryban, L., Plyushch, T., Wagner, G. A., Fenzl, S., Dremsek, P., Cabaravdic, M., Steiner, M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.258814 · Cited by 75
AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis.
Nazarian, R., & Weinberg, J. M. (2009) · PubMed · Cited by 74
Dent, G., Giembycz, M. A., Rabe, K. F., Wolf, B., Barnes, P. J., & MAGNUSSEN, H. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179921 · Cited by 71
Plectranthus barbatus: A Review of Phytochemistry, Ethnobotanical Uses and Pharmacology – Part 2
Alasbahi, R. H., & Melzig, M. F. (2010) · Planta Medica · doi:10.1055/s-0029-1240919 · Cited by 70
Degradation of target protein in living cells by small-molecule proteolysis inducer
Zhang, D., Baek, S.-H., Ho, A., & Kim, K. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.042 · Cited by 69
Dopamine Receptors Modulate Cytotoxicity of Natural Killer Cells via cAMP-PKA-CREB Signaling Pathway
Zhao, W., Huang, Y., Liu, Z., Cao, B.-B., Peng, Y.-P., & Qiu, Y.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065860 · Cited by 68
Vaeth, M., Gogishvili, T., Bopp, T., Klein, M., Berberich‐Siebelt, F., Gattenloehner, S., Avots, A., Sparwasser, T. D., Grebe, N., Schmitt, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009463108 · Cited by 67
Hofmann, B., Nishanian, P., Nguyen, T. D., et al. (1993) · AIDS · doi:10.1097/00002030-199305000-00008 · Cited by 63
Generation and functions of second messengers microdomains
Filadi, R., & Pozzan, T. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.03.007 · Cited by 62
2 PDE4 Inhibitors – A Review of the Current Field
Press, N. J., & Banner, K. H. (2009) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)00202-6 · Cited by 60
Forskolin Derivatives with Increased Selectivity for Cardiac Adenylyl Cyclase
Toya, Y., Schwencke, C., & Ishikawa, Y. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0575 · Cited by 56
A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast
Chiricozzi, A., Caposiena, D. R., Garofalo, V., Cannizzaro, M. V., Chimenti, S., & Saraceno, R. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1134319 · Cited by 56
Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma
Lee, J., Kim, T. H., Murray, F., Li, X., Choi, S. S., Broide, D. H., Corr, M., Lee, J., Webster, N. J. G., Insel, P. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417972112 · Cited by 55
Oger, S., Méhats, C., Dallot, E., CABROL, D., & Leroy, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8082 · Cited by 54
Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active.
Loriaux, M., Rehfuss, R. P., Brennan, R. G., & Goodman, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9046 · Cited by 54
PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
Diamant, Z., & Spina, D. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.12.011 · Cited by 53
Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics
Appleman, L. J., Tzachanis, D., Grader‐Beck, T., van Puijenbroek, A. A. F. L., & Boussiotis, V. A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000180 · Cited by 53
Human Immunodeficiency Virus Replication: Modulation by Cellular Levels of cAMP
Nokta, M. A., & Pollard, R. B. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1255 · Cited by 50
Gilbert, K. M., & Hoffmann, M. K. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2084 · Cited by 49
Phosphodiesterase 7A: A New Therapeutic Target for Alleviating Chronic Inflammation?
Giembycz, M. A., & Smith, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778194123 · Cited by 49
Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors
Sciaraffia, E., Riccomi, A., Lindstedt, R., Gesa, V., Cirelli, E., Patrizio, M., Magistris, M. T. D., & Vendetti, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0513-302rr · Cited by 49
Levy, F. O., Rasmussen, A., Taskén, K., Skålhegg, B. S., Huitfeldt, H. S., Funderud, S., Smeland, E. B., & Hansson, V. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260617 · Cited by 47
Faßbender, M., Gerlitzki, B., Ullrich, N., Lupp, C., Klein, M., Radsak, M. P., Schmitt, E., Bopp, T., & Schild, H. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.07.007 · Cited by 47
Begum, N., Shen, W., & Manganiello, V. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.006 · Cited by 46
Klein, M., Vaeth, M., Scheel, T., Grabbe, S., Baumgrass, R., Berberich‐Siebelt, F., Bopp, T., Schmitt, E., & Becker, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102045 · Cited by 41
Self-citationSAR156497, an Exquisitely Selective Inhibitor of Aurora Kinases
Carry, J., Clerc, F., Minoux, H., Schio, L., Mauger, J., Nair, A. C., Parmantier, E., Moigne, R. L., Delorme, C., Nicolas, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501326k · Cited by 39
Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells
Bazhin, A. V., Kahnert, S., Kimpfler, S., Schadendorf, D., & Umansky, V. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.032 · Cited by 38
Mulhall, A. M., Droege, C. A., Ernst, N. E., Panos, R. J., & Zafar, M. A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1094054 · Cited by 37
PROTAC-Induced Proteolytic Targeting
Carmony, K. C., & Kim, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-474-2_44 · Cited by 36
Wang, Z., Zhang, Y., Zhang, H., & Li, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826115559 · Cited by 36
Martin, H., Reuter, S., Dehzad, N., Heinz, A., Bellinghausen, I., Saloga, J., Haasler, I., Korn, S., Jonuleit, H., Buhl, R., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.038 · Cited by 35
Self-citationKadoshima-Yamaoka, K., Murakawa, M., Goto, M., Tanaka, Y., Inoue, H., Murafuji, H., Hayashi, Y., Nagahira, K., Miura, K., Nakatsuka, T., et al. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.005 · Cited by 30
Goto, M., Murakawa, M., Kadoshima-Yamaoka, K., et al. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.04.005 · Cited by 30
Peripheral Mechanisms II: The Pharmacology of Peripherally Active Antitussive Drugs
Spina, D., McFadzean, I., Bertram, F., & Page, C. P. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-79842-2_8 · Cited by 28
Connexin 43 Signaling Enhances the Generation of Foxp3+ Regulatory T Cells
Kuczma, M., Lee, J. R., & Kraj, P. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003785 · Cited by 27
Rahmouni, S., Aandahl, E. M., Nayjib, B., Zeddou, M., Giannini, S. L., Verlaet, M., Greimers, R., BONIVER, J., Taskén, K., & Moutschen, M. P. (2004) · Biochemical Journal · doi:10.1042/bj20031859 · Cited by 26
cAMP: fuel for extracellular adenosine formation?
Gödecke, A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.7 · Cited by 25
Liopeta, K., Boubali, S., Virgilio, L., Thyphronitis, G., Mavrothalassitis, G., Dimitracopoulos, G., & Paliogianni, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.10.025 · Cited by 24
Elevation of Intracellular Cyclic AMP Induces an Anergic-like State in Th1 Clones
Cone, R. E., Cochrane, R., Lingenheld, E. G., & Clark, R. B. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0274 · Cited by 23
Braeuning, A. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-1002-4 · Cited by 7
Cited by
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 378
Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
Baillie, G. S., Tejeda, G. S., & Kelly, M. P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0033-4 · Cited by 339
Targeting cell signaling in allergic asthma
Athari, S. S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0079-0 · Cited by 312
Huang, B., Chen, Z., Geng, L., Wang, J., Liang, H., Cao, Y., Chen, H., Huang, W., Su, M., Wang, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.027 · Cited by 307
Wallrapp, A., Burkett, P. R., Riesenfeld, S. J., Kim, S.-J., Christian, E., Abdulnour, R.-E. E., Thakore, P. I., Schnell, A., Lambden, C., Herbst, R. H., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.005 · Cited by 261
Metadata
- Authors
- Raker, V. K., Becker, C., & Steinbrink, K.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2016-03-31
- Volume
- 7
- Pages
- 123-123
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2329012680
- Cited by
- 319
- References
- 141
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.